# Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

> **NCT06855394** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 13000 (estimated)

## Conditions studied

- Atherosclerotic Vascular Disease
- Coronary Arterial Disease (CAD)
- Atherosclerosis of Coronary Artery
- Atherosclerosis of Arteries of the Extremities, Unspecified
- Heart Diseases
- Stroke
- Venous Thromboembolic Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06855394
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 13000 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06855394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06855394, "Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06855394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*